Key result
ICD lead extraction after successful VT ablation remains controversial with no controlled data available, and may be considered only in highly selected patients after a suitable follow-up.
Why the study?
Does transvenous lead extraction improve outcomes compared to device retention or lead abandonment in ICD patients who have been successfully treated by means of ablation of their ventricular arrhythmias?
Does transvenous lead extraction improve outcomes compared to device retention or lead abandonment in ICD patients who have been successfully treated by means of ablation of their ventricular arrhythmias?
The indication for ICD extraction after successful VT ablation remains questionable and requires individualized risk-benefit assessment due to the lack of controlled data.
Requires individualized risk-benefit assessment now; leaves open the need for controlled trials comparing extraction to retention after VT ablation.
Sustained ventricular tachyarrhythmias represent a kind of complication shared by a number of clinical presentations of heart disease, sometimes leading to sudden cardiac death. Many efforts have been made in the fight against such a complication, mainly being represented by the implantable cardioverter defibrillator (ICD). In recent years, catheter ablation has grown as a means to effectively treat patients with sustained ventricular arrhythmias, in the contest of different cardiac substrates. Since carrying an ICD is associated with a potential risk deriving from its possible infective or malfunctioning complications, and given the current effectiveness of lead extraction procedures, it has been thought not to be unreasonable to ask ourselves about how to deal with ICD patients who have been successfully treated by means of ablation of their ventricular arrhythmias. To date, no control data have been published on transvenous lead extraction in the setting of VT ablation. In this paper we will review the current evidence about ICD therapy, catheter ablation of ventricular arrhythmias and lead extraction, trying to outline some considerations about how to face this new clinical issue.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a review in Ventricular tachycardia in patients with implantable cardioverter defibrillators. ICD lead extraction after successful VT ablation vs. Lead abandonment or wait-and-see approach was evaluated. ICD lead extraction after successful VT ablation remains controversial with no controlled data available, and may be considered only in highly selected patients after a suitable follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: